Some studies have shown that the level of ASM is increased in the plasma of T2DM patients, which inhibits the repair potential of mature retinal endothelial cells and circulating angiogenic cells, and inhibiting ASM activity can significantly improve the level of type 2 diabetes retinopathy (Ensari et al. 2021). The gene discussed is SMPD1; the disease is type 2 diabetes mellitus.